drugset / Trial / NCT03720899

Comparing NicoBloc to Nicotine Lozenges

NCT03720899

Phase 2/3 Completed 45 enrolled University of Alabama at Birmingham
RandomizedParallel-groupOpen-labelTreatment

Summary

To examine the feasibility, acceptability, and preliminary impact of using NicoBloc compared to nicotine lozenges

Timeline

Start
2019-03-21
Primary completion
2021-01-03
Completion
2021-03-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Nicotine Unknown 2 mg
Comparator Nicotine Unknown 4 mg

Indications